FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945332186> ?p ?o ?g. }

• W2945332186 endingPage "e15709" @default.
• W2945332186 startingPage "e15709" @default.
• W2945332186 abstract "Abstract Background: It is uncertain if dexmedetomidine has more favorable pharmacokinetic profile than the traditional sedative drug propofol in patients who undergo endovascular therapy for acute stroke. We conducted a prospective randomized control trial to compare the safety and efficacy of dexmedetomidine with propofol for patients undergoing endovascular therapy for acute stroke. Methods: A total of 80 patients who met study inclusion criteria were received either propofol (n = 45) or dexmedetomidine (n = 35) between January 2016 and August 2018. We recorded the favorable neurologic outcome (modified Rankin score <3) both at discharge and 3 months after stroke, National Institute of Health Stroke scale (NIHSS) at 48 hours post intervention, modified thrombolysis in myocardial infarction score on digital subtraction angiography, intraprocedural hemodynamics, recovery time, relevant time intervals, satisfaction score of the surgeon, mortality, and complications. Results: There were no significant differences between the 2 groups ( P > .05) with respect to heart rate, respiratory rate, and SPO 2 during the procedure. The mean arterial pressure (MAP) was significantly low in the propofol group until 15 minutes after anesthesia was induced. No difference was recorded between the groups at the incidence of fall in MAP >20%, MAP >40% and time spent with MAP fall >20% from baseline MAP. In the propofol group, the time spent with MAP fall >40% from baseline MAP was significantly long ( P < .05). Midazolam and fentanyl were similar between the 2 groups ( P > .05) that used vasoactive drugs. The time interval from stroke onset to CT room, from stroke onset to groin puncture, and from stroke onset to recanalization/end of the procedure, was not significantly different between the 2 groups ( P > .05). The recovery time was longer in the dexmedetomidine group ( P < .05). There was no difference between the groups with respect to complications, favorable neurological outcome, and mortality both at hospital discharge and 3 months later, successful recanalization and NIHSS score after 48 hours ( P > .05). However, the satisfaction score of the surgeon was higher in the dexmedetomidine group ( P < .05). Conclusions: Dexmedetomidine was undesirable than propofol as a sedative agent during endovascular therapy in patients with acute stroke for a long-term functional outcome, though the satisfaction score of the surgeon was higher in the dexmedetomidine group." @default.
• W2945332186 created "2019-05-29" @default.
• W2945332186 creator A5018782244 @default.
• W2945332186 creator A5037594628 @default.
• W2945332186 creator A5071388206 @default.
• W2945332186 creator A5079536649 @default.
• W2945332186 creator A5082833740 @default.
• W2945332186 date "2019-05-01" @default.
• W2945332186 modified "2023-09-25" @default.
• W2945332186 title "The safety and efficacy of dexmedetomidine versus propofol for patients undergoing endovascular therapy for acute stroke" @default.
• W2945332186 cites W1893217911 @default.
• W2945332186 cites W1920661025 @default.
• W2945332186 cites W2020637237 @default.
• W2945332186 cites W2062960487 @default.
• W2945332186 cites W2087992743 @default.
• W2945332186 cites W2088533402 @default.
• W2945332186 cites W2096828144 @default.
• W2945332186 cites W2126558561 @default.
• W2945332186 cites W2131334137 @default.
• W2945332186 cites W2133778302 @default.
• W2945332186 cites W2134481016 @default.
• W2945332186 cites W2137724332 @default.
• W2945332186 cites W2147829586 @default.
• W2945332186 cites W2150189472 @default.
• W2945332186 cites W2153664287 @default.
• W2945332186 cites W2176191911 @default.
• W2945332186 cites W2239863455 @default.
• W2945332186 cites W2271820424 @default.
• W2945332186 cites W2286350689 @default.
• W2945332186 cites W2316216946 @default.
• W2945332186 cites W2339958467 @default.
• W2945332186 cites W2340656341 @default.
• W2945332186 cites W2342064370 @default.
• W2945332186 cites W2395928854 @default.
• W2945332186 cites W2410342105 @default.
• W2945332186 cites W2490417864 @default.
• W2945332186 cites W2545700215 @default.
• W2945332186 cites W2548174585 @default.
• W2945332186 cites W2572055588 @default.
• W2945332186 cites W2596035162 @default.
• W2945332186 cites W2609546402 @default.
• W2945332186 cites W2614647631 @default.
• W2945332186 cites W2616135419 @default.
• W2945332186 cites W2734652755 @default.
• W2945332186 cites W2743465491 @default.
• W2945332186 cites W2754273395 @default.
• W2945332186 cites W2760159577 @default.
• W2945332186 cites W2766156151 @default.
• W2945332186 cites W2769899333 @default.
• W2945332186 cites W2801213796 @default.
• W2945332186 cites W2804652288 @default.
• W2945332186 cites W4229005747 @default.
• W2945332186 doi "https://doi.org/10.1097/md.0000000000015709" @default.
• W2945332186 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6571375" @default.
• W2945332186 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31124948" @default.
• W2945332186 hasPublicationYear "2019" @default.
• W2945332186 type Work @default.
• W2945332186 sameAs 2945332186 @default.
• W2945332186 citedByCount "5" @default.
• W2945332186 countsByYear W29453321862020 @default.
• W2945332186 countsByYear W29453321862021 @default.
• W2945332186 countsByYear W29453321862022 @default.
• W2945332186 countsByYear W29453321862023 @default.
• W2945332186 crossrefType "journal-article" @default.
• W2945332186 hasAuthorship W2945332186A5018782244 @default.
• W2945332186 hasAuthorship W2945332186A5037594628 @default.
• W2945332186 hasAuthorship W2945332186A5071388206 @default.
• W2945332186 hasAuthorship W2945332186A5079536649 @default.
• W2945332186 hasAuthorship W2945332186A5082833740 @default.
• W2945332186 hasBestOaLocation W29453321861 @default.
• W2945332186 hasConcept C126322002 @default.
• W2945332186 hasConcept C127413603 @default.
• W2945332186 hasConcept C164705383 @default.
• W2945332186 hasConcept C197934379 @default.
• W2945332186 hasConcept C2776277131 @default.
• W2945332186 hasConcept C2776452961 @default.
• W2945332186 hasConcept C2776814716 @default.
• W2945332186 hasConcept C2777953023 @default.
• W2945332186 hasConcept C2778000748 @default.
• W2945332186 hasConcept C2779581417 @default.
• W2945332186 hasConcept C2780645631 @default.
• W2945332186 hasConcept C2780931571 @default.
• W2945332186 hasConcept C2781072394 @default.
• W2945332186 hasConcept C2781302539 @default.
• W2945332186 hasConcept C3020199598 @default.
• W2945332186 hasConcept C42219234 @default.
• W2945332186 hasConcept C500558357 @default.
• W2945332186 hasConcept C541997718 @default.
• W2945332186 hasConcept C71924100 @default.
• W2945332186 hasConcept C78519656 @default.
• W2945332186 hasConcept C84393581 @default.
• W2945332186 hasConceptScore W2945332186C126322002 @default.
• W2945332186 hasConceptScore W2945332186C127413603 @default.
• W2945332186 hasConceptScore W2945332186C164705383 @default.
• W2945332186 hasConceptScore W2945332186C197934379 @default.
• W2945332186 hasConceptScore W2945332186C2776277131 @default.
• W2945332186 hasConceptScore W2945332186C2776452961 @default.
• W2945332186 hasConceptScore W2945332186C2776814716 @default.

• next